The Ptx (Pitx) family of homeobox transcription factors comprises Ptx1, Ptx2 and Ptx3. Ptx1 and Ptx2 are expressed in the stomodeum and its derivatives including the pituitary, as well as in mesodermal derivatives, whereas Ptx3 is expressed in one neuronal lineage of the brain and in the eyes. A large set of downstream target genes have been identified for Ptx1 in the pituitary gland where it acts as a pan-pituitary regulator of transcription. In particular, Ptx1 contributes to promoter- and lineage-specific transcription by interaction with cell-restricted factors such as SF-1, Egr-1, Pit1, and the basic helix-loop-helix heterodimer NeuroD1/Pan1. We describe the cloning from pituitary cells and the characterization of a Ptx1 isoform, named Ptx1b, generated by alternative promoter usage. The two Ptx1 and two Ptx2 isoforms have similar in vitro DNA binding specificities and they all activate transcription driven by a panel of pituitary promoters, including those for proopiomelanocortin, αGSU, LHβ, FSHβ, GnRH-R, TSHβ, PRL, and GH. Also like Ptx1, the Ptx1b, Ptx2a, and Ptx2b transcription factors synergize with the structurally unrelated factors SF-1, Egr-1, Pit1, and NeuroD1/Pan1 to activate promoter-specific transcription. In conclusion, the pituitary transcriptional activities of the four Ptx isoforms do not appear to be dependent on the variant N-termini of these factors.

Keywords:
Pituitary, Transcription factors, Hormone-coding genes, Homeodomain, Pitx family, Cell-specific transcription, Molecular neuroendocrinology
1.
Lamonerie T, Tremblay JJ, Lanctôt C, Therrien M, Gauthier Y, Drouin J: PTX1, a bicoid-related homeobox transcription factor involved in transcription of pro-opiomelanocortin (POMC) gene. Genes Dev 1996;10:1284–1295.
2.
Tremblay JJ, Lanctôt C, Drouin J: The pan-pituitary activator of transcription, Ptx-1 (pituitary homeobox1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3. Mol Endocrinol 1998;12:428–441.
3.
Szeto DP, Ryan AK, O’Connell SM, Rosenfeld MG: P-OTX: A PIT-1-interacting homeodomain factor expressed during anterior pituitary gland development. Proc Natl Acad Sci USA 1996;93:7706–7710.
4.
Poulin G, Turgeon B, Drouin J: NeurolD1/ beta 2 contributes to cell-specific transcription of the proopiomelanocortin gene. Mol Cell Biol 1997;17:6673–6682.
5.
Tremblay JJ, Marcil A, Gauthier Y, Drouin J: Ptx1 regulates SF-1 activity by an interaction that mimics the role of the ligand-binding domain. EMBO J 1999;18:3431–3441.
6.
Tremblay JJ, Drouin J: Erg-1 is a downstream effector of GnRH and synergizes by direct interaction with Ptx1 and SF-1 to enhance luteinizing hormone β gene transcription. Mol Cell Biol 1999;19:2567–2576.
7.
Drouin J, Lanctôt C, Tremblay JJ: La famille Ptx des facteurs de transcription à homéodomaine. Méd Sci 1998;14:335–339.
8.
Gage PJ, Camper SA: Pituitary homeobox 2, a novel member of the bicoid-related family of homeobox genes, is a potential regulator of anterior structure formation. Hum Mol Genet 1997;6:457–464.
9.
Muccielli ML, Martinez S, Pattyn A, Goridis C, Brunet JF: Otlx2, an Otx-related homeobox gene expressed in the pituitary gland and in a restricted pattern in the forebrain. Mol Cell Neurosci 1996;8:258–271.
10.
Semina EV, Reiter R, Leysens NJ, Alward WL, Small KW, Datson NA, Siegel-Bartelt J, Bierke-Nelson D, Bitoun P, Zabel BU, Carey JC, Murray JC: Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet 1996;14:392–399.
11.
Arakawa H, Nakamura T, Zhadanov AB, Fidanza V, Yano T, Bullrich F, Shizumi M, Blechman J, Mazo A, Canaani E, Croce CM: Identification and characterization of the ARP1 gene, a target for the human acute leukemia ALL1 gene. Proc Natl Acad Sci USA 1998;95:4573–4578.
12.
Smidt M, van Schaick HSA, Lanctôt C, Tremblay JJ, Cox JJ, van der Kleij AAM, Wolterink G, Drouin J, Burbach PH: A homeodomain gene PTX3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc Natl Acad Sci USA 1997;94:13305–13310.
13.
Semina EV, Reiter RS, Murray J: Isolation of a new homeobox gene belonging to the Pitx/Rieg family: Expression during lens development and mapping to the aphakia region on mouse chromosome 19. Hum Mol Genet 1997;6:2109–2116.
14.
Lanctôt C, Lamolet B, Drouin J: The bicoid-related homeoprotein Ptx1 defines the most anterior domain of the embryo and differentiates posterior from anterior lateral mesoderm. Development 1997;124:2807–2817.
15.
Sheng HZ, Zhadanov AB, Mosinger B, Fujii T, Bertuzzi S, Grinberg A, Lee EJ, Huang SP, Mahon KA, Westphal H: Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science 1996;272:1004–1007.
16.
Lanctôt C, Moreau A, Chamberland M, Tremblay ML, Drouin J: Hindlimb patterning and mandible development require the Ptx1 gene. Development 1999;126:1805–1810.
17.
Szeto DP, Rodriguez-Esteban C, Ryan AK, O’Connell S, Liu R, Kioussi C, Gleiberman AS, Izpisua-Belmonte JC, Rosenfeld MG: Role of the bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development. Genes Dev 1999;13:484–494.
18.
Logan M, Tabin CJ: Role of Pitx1 upstream of Tbx4 in specification of hindlimb identity. Science 1999;283:1736–1739.
19.
Harvey RP: Links in the left/right axial pathway. Cell 1998;94:273–276.
20.
Yoshioka H, Meno C, Koshiba K, Sugihara M, Itoh H, Ishimaru Y, Inoue T, Ohuchi H, Semina EV, Murray JC, Hamada H, Noji S: Pitx2, a bicoid-type homeobox gene, is involved in a lefty-signaling pathway in determination of left-right asymmetry. Cell 1998;94:299–305.
21.
Logan M, Pagán-Westphal SM, Smith DM, Paganessi L, Tabin CJ: The transcription factor Pitx2 mediates situs-specific morphogenesis in response to left-right asymmetric signals. Cell 1998;94:307–317.
22.
Piedra ME, Icardo JM, Albajar M, Rodriguez-Rey JC, Ros MA: Pitx2 participates in the late phase of the pathway controlling left-right asymmetry. Cell 1998;94:319–324.
23.
Ryan AK, Blumberg B, Rodriguez-Esteban C, Yonei-Tamura S, Tamura I, Tsukui T, de la Peña J, Sabbagh W, Greenwald J, Choe S, Norris DP, Robertson EJ, Evans RM, Rosenfeld MG, Izpisúa Belmonte JC: Pitx2 determines left-right asymmetry of internal organs in vertebrates. Nature 1998;394:545–551.
24.
Bürglin TR: A comprehensive classification of homeobox genes; in Duboule D (ed): Guidebook to the Homeobox Genes, Oxford University Press 1993, pp 25–71.
25.
Wilson DS, Sheng G, Jun S, Desplan C: Conservation and diversification in homeodomain-DNA interactions: A comparative genetic analysis. Proc Natl Acad Sci USA 1996;93:6886–6891.
26.
Driever W, Nusslein-Volhard C: The bicoid protein is a positive regulator of hunchback transcription in the early Drosophila embryo. Nature 1989;337:138–143.
27.
Acampora D, Mazan S, Tuorto F, Avantaggiato V, Tremblay JJ, Lazzaro D, di Carlo A, Mariano PE, Corte G, Macchia V, Drouin J, Brûlet P, Simeone A: Transient dwarfism and hypogonadism in mice lacking Otx1 reveal prepubescent stage-specific control of pituitary levels of GH, FSH and LH. Development 1998;125:1229–1239.
28.
Bodner M, Castrillo JL, Theill LE, Deerinck T, Ellisman M, Karin M: The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell 1988;55:505–518.
29.
Ingraham HA, Chen R, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR, Simmons DM, Swanson L, Rosenfeld MG: A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 1988;55:519–529.
30.
Konzak KE, Moore DD: Functional isoforms of Pit-1 generated by alternative messenger RNA splicing. Mol Endocrinol 1992;6:241–247.
31.
Morris AE, Kloss B, McChesney RE, Bancroft C, Chasin LA: An alternatively spliced Pit-1 isoform altered in its ability to trans-activate. Nucleic Acids Res 1992;20:1355–1361.
32.
Haugen BR, Wood WM, Gordon DF, Ridgway EC: A thyrotrope-specific variant of Pit-1 transactivates the thyrotropin beta promoter. J Biol Chem 1993;268:20818–20824.
33.
Day RN, Day KH: An alternatively spliced form of Pit-1 represses prolactin gene expression. Mol Endocrinol 1994;8:374–381.
34.
Voss JW, Wilson L, Rhodes SJ, Rosenfeld MG: An alternative Pit-1 RNA splicing product reveals modular binding and nonmodular transcriptional activities of the POU-specific domain. Mol Endocrinol 1993;7:1551–1560.
35.
Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463–5467.
36.
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thyocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–159.
37.
Philips A, Lesage S, Gingras R, Maira MH, Gauthier Y, Hugo P, Drouin J: Novel dimeric Nur77 signaling mechanisms in endocrine and lymphoid cells. Mol Cell Biol 1997;17:5946–5951.
38.
Therrien M, Drouin J: Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene. Mol Cell Biol 1993;13:2342–2353.
39.
Kozak M: Compilation and analysis of sequences upstream from the translation start site in eukaryotic mRNAs. Nucleic Acids Res 1984;12:857–872.
40.
Lanctôt C, Gauthier Y, Drouin J: Pituitary homeobox 1 (Ptx1) is differentially expressed during pituitary development. Endocrinology 1999;140:1416–1422.
41.
Ma X, Yuan D, Diepold K, Scarborough T, Ma J: The drosophila morphogenetic protein bicoid binds DNA cooperatively. Development 1996;122:1195–1206.
42.
Ko LJ, Engel JD: DNA-binding specificities of the GATA transcription factor family. Mol Cell Biol 1993;13:4011–4022.
43.
Mann RS, Chan SK: Extra specificity from extradenticle: The partnership between HOX and PBX/EXD homeodomain proteins. Trends Genet 1996;12:258–262, 328 (erratum).
44.
Phelan ML, Rambaldi I, Featherstone MS: Cooperative interactions between HOX and PBX proteins mediated by a conserved peptide motif. Mol Cell Biol 1995;15:3989–3997.
45.
Chang CP, Shen WF, Rozenfeld S, Lawrence HJ, Largman C, Cleary ML: Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. Genes Dev 1995;9:663–674.
46.
Lu Q, Kamps MP: Structural determinants within Pbx1 that mediate cooperative DNA binding with pentapeptide-containing Hox proteins: Proposal for a model of a Pbx1-Hox-DNA complex. Mol Cell Biol 1996;16:1632–1640.
47.
Peltenburg LTC, Murre C: Specific residues in the PBX homeodomain differentially modulate the DNA-binding activity of Hox and engrailed proteins. Development 1997;124:1089–1098.
48.
Knoepfler PS, Calvo KR, Chen H, Antonarakis SE, Kamps MP: Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proc Natl Acad Sci USA 1997;94:14553–14558.
49.
Chang CP, Jacobs Y, Nakamura T, Jenkins NA, Copeland NG, Cleary ML: Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins. Mol Cell Biol 1997;17:5679–5687.
50.
Acampora D, Avantaggiato V, Tuorto F, Barone P, Perera M, Choo D, Wu D, Corte G, Simeone A: Differential transcriptional control as the major molecular event in generating Otx1-/- and Otx2-/- divergent phenotypes. Development 1999;126:1417–1426.
51.
Acampora D, Avantaggiato V, Tuorto F, Briata P, Corte G, Simeone A: Visceral endoderm-restricted translation of Otx1 mediates recovery of Otx2 requirements for specification of anterior neural plate and normal gastrulation. Development 1998;125:5091–5104.
52.
Simmons DM, Voss JW, Ingraham HA, Holloway JM, Broide RS, Rosenfeld MG, Swanson LW: Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev 1990;4:695–711.
53.
Dollé P, Castrillo JL, Theill LE, Deerinck T, Ellisman M, Karin M: Expression of GHF-1 protein in mouse pituitaries correlates both temporally and spatially with the onset of growth hormone gene activity. Cell 1990;60:809–820.
54.
Andersen B, Rosenfeld MG: Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J Biol Chem 1994;269:29335–29338.
55.
Hermesz E, Mackem S, Mahon KA: Rpx: A novel anterior-restricted homeobox gene progessively activated in the prechordal plate, anterior neural plate and Rathke’s pouch of the mouse embryo. Development 1996;122:41–52.
56.
Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O’Connell SM, Gukovsky I, Carriere C, Ryan AK, Miller AP, Zuo L, Gleiberman AS, Andersen B, Beamer WG, Rosenfeld MG: Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 1996;384:327–333.
57.
Logan M, Simon HG, Tabin C: Differential regulation of T-box and homeobox transcription factors suggests role in controlling chick limb-type identity. Development 1998;125:2825–2835.
58.
Mucchielli ML, Mitsiadis TA, Raffo S, Brunet JF, Proust JP, Goridis C: Mouse Otlx2/RIEG expression in the odontogenic epithelium precedes tooth initiation and requires mesenchyme-derived signal for its maintenance. Dev Biol 1997;189:275–284.
59.
Campione M, Steinbeisser H, Schweickert A, Deissler K, van Bebber F, Lowe LA, Nowotschin S, Viebahn C, Haffter P, Kuehn MR, Blum M: The homeobox gene Ptx2: Mediator of asymmetric left-right signaling in vertebrate heart and gut looping. Development 1999;126:1225–1234.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.